On September 21, 2016, Yang, Caiyun published a patent.Related Products of 23256-42-0 The title of the patent was Compound care agent for treating chronic pyelonephritis and preparation method thereof. And the patent contained the following:
The present invention discloses a compound care agent for treating chronic pyelonephritis and preparation method thereof. The compound care agent for treating chronic pyelonephritis comprises sulfamethazine, trovafloxacin mesylate, clavulanate potassium, coated aldehyde starch oxide, imipenem, finasteride, tocopheryl acetate, coptisine, proglumetacin dipeptide, colloidal bismuth subcitrate, demetionine 1,4-butanedisulfonate, trimethoprim lactate, and vitamin C. The compound care agent of the present invention has antibacterial anti-inflammatory, nourishing liver and kidney, Qi and blood, and detoxification effects, and can effectively eliminate inflammation, repair renal function, promote kidney metabolism, and improve the immunity of the patients. Proved by clin., the compound agent of the invention for the treatment of chronic pyelonephritis, has obvious curative effect, high safety, low side effects, and good long term application prospect. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Related Products of 23256-42-0
The Article related to care agent chronic pyelonephritis, Pharmaceuticals: Formulation and Compounding and other aspects.Related Products of 23256-42-0
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia